TL;DR
This study reveals that intermittent fasting (IF), particularly when combined with a balanced diet, can reverse obesity-induced metabolic and neurological deficits in mice. A key finding is the identification of succinate, a metabolic intermediate, as a crucial mediator of these benefits, suggesting it could be a novel therapeutic target for obesity-related disorders.
What Problem Does This Paper Address?
Obesity is a major health concern, linked to a host of metabolic diseases and neurocognitive impairments like dementia and anxiety. While intermittent fasting (IF) has shown promise in improving health outcomes, the underlying mechanisms remain largely unknown. This paper aims to elucidate these mechanisms by investigating how IF, in conjunction with dietary changes, impacts the brain and metabolism in a diet-induced obesity (DIO) mouse model. Specifically, it seeks to understand how IF influences brain function, metabolic health, and whether specific molecular pathways are involved in these improvements.
Methods
The researchers employed a multi-pronged approach using a DIO mouse model. They compared four groups: mice on a high-fat diet (HFD), HFD with intermittent fasting (HFD-IF), mice on a control chow diet (CC), and CC with intermittent fasting (CC-IF).
Key techniques included:
- Metabolic and Behavioral Assessments: Measuring body weight, fat mass, glucose tolerance, insulin levels, and performing a battery of behavioral tests (open-field, Y-maze, elevated plus maze, novel object recognition) to assess anxiety, exploration, and memory.
- Transcriptomics (RNA-sequencing): Analyzing gene expression in the hippocampus and liver to identify molecular pathways affected by diet and IF.
- Metabolomics: Quantifying levels of various metabolites, particularly those in the TCA cycle, in plasma, liver, hippocampus, and brown adipose tissue (BAT).
- Succinate Supplementation: Administering sodium succinate to DIO mice to directly test its role in mimicking the beneficial effects of IF.
- Immunofluorescence: Examining inflammatory markers (IL-1β, TNFα) and microglia morphology in the hippocampus.
Datasets
Not discussed in the paper.
Key Insights and Ideas
- CC-IF is a potent intervention: Combining intermittent fasting with a balanced control diet (CC-IF) yielded the most significant improvements in metabolic parameters and behavioral outcomes, even surpassing IF alone on an HFD.
- Succinate as a key player: The study identified a unique "succinate signature" in CC-IF mice – decreased plasma levels and increased levels in the liver and BAT. This metabolic shift appears to be a central mechanism driving the observed benefits.
- Succinate supplementation recapitulates IF benefits: Directly administering succinate to DIO mice mimicked many of the positive effects seen with CC-IF, including improved glucose tolerance, reduced anxiety, and reduced neuroinflammation. This strongly implicates succinate as a mediator.
- Neuroinflammation is a target: HFD induced hippocampal neuroinflammation, which was ameliorated by CC-IF and succinate supplementation, suggesting a direct impact on brain health beyond just metabolic improvements.
- Context matters for succinate: The effectiveness of succinate supplementation on weight loss was context-dependent, being more pronounced when combined with a healthy background diet (CC-Succ) compared to an HFD (HFD-Succ).
Key Results
- Metabolic Improvements: CC-IF significantly reduced body weight, fat mass (especially epididymal and perirenal fat), and improved glucose tolerance and insulin sensitivity compared to HFD.
- Behavioral Enhancements: CC-IF uniquely enhanced exploration and reduced anxiety-like behavior, as evidenced by increased unsupported rearing, more entries into the open arm of the EPM, and a lower emotionality score.
- Molecular Signatures: Transcriptomic analysis revealed HFD-induced hippocampal neuroinflammation. Metabolomic analysis showed a specific succinate profile in CC-IF mice (low plasma, high liver/BAT).
- Succinate Efficacy: Succinate supplementation in DIO mice led to significant improvements in glucose tolerance and reduced anxiety-like behavior, mirroring CC-IF effects. It also reduced pro-inflammatory cytokines (IL-1β, TNFα) in the hippocampus.
Limitations and Future Work
- Translational Relevance: While promising, the study was conducted in mice. Further research is needed to confirm these findings in humans, particularly regarding the role of succinate in obesity and related disorders.
- Mechanism of Succinate Action: The precise mechanisms by which succinate exerts its effects, especially its interaction with the brain and its role in BAT thermogenesis, require further investigation. The study suggests a potential "metabolic vacuum" effect of BAT and liver on circulating succinate.
- Gut Microbiota: The authors acknowledge that IF mechanisms might involve modulation of the gut microbiota, which was not directly investigated in this study.
- Long-term Effects: The study focused on a 4-week intervention period. Longer-term studies would be beneficial to assess sustained effects.
- Specific IF Regimens: The study focused on alternate-day fasting. Exploring other IF protocols could yield different insights.
Summary updated